Table 1.
Patient characteristics (n = 178).
| variable | |
|---|---|
| Median age, years (range) | 72 (46-91) |
| PSA at diagnosis, median (range) | 164 (3.2-8740) |
| Biopsy Gleason score, n (%) | |
| ≤6 | 5 (2.8) |
| 7 | 29 (16.2) |
| ≥8 | 129 (72.4) |
| not available | 15 (8.4) |
| cT stage, n (%) | |
| T1c | 1 (0.5) |
| T2a | 4 (2.2) |
| T2b | 5 (2.8) |
| T2c | 1 (0.5) |
| T3a | 64 (35.9) |
| T3b | 43 (24.1) |
| T4 | 52 (29.2) |
| not available | 8 (4.4) |
| cN stage | |
| N0 | 59 (33.1) |
| N1 | 116 (65.1) |
| not available | 3 (1.6) |
| cM stage | |
| M0 | 19 (10.6) |
| M1 | 157 (88.2) |
| not available | 2 (1.1) |
| Median testosterone, ng/dl (range) | 400 (37-1042) |
| Median BMI, kg/m2 (range) | 22.5 (14.5-31.1) |
| Median visceral fat, % (range) | 29.4 (2.1-57.6) |
| Median V/S ratio, ratio (range) | 1.16 (0.34-19.6) |
| Psoas muscle ratio, ratio (range) | 1.95 (0.71-3.64) |
| hormonal therapy | |
| Castration | 11 (6.2) |
| Combined androgen blockage | 167 (93.8) |
Abbreviations: BMI, body mass index; PSA, prostate-specific antigen; V/S ratio, Visceral fat/subcutaneous fat ratio.
Psoas muscle ratio: Psoas muscle/height (cm3/cm).